Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.52 | N/A |
| PEG Ratio (TTM) | -1.14 | N/A |
| P/S Ratio (TTM) | 0.37 | N/A |
| P/B Ratio (TTM) | 0.73 | N/A |
| P/FCF Ratio (TTM) | 2.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.11 | N/A |
| Price to 5YR AVG FCF Ratio | 22.98 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.80% | N/A |
| ROE (TTM) | 5.91% | N/A |
| Net Profit Margin (TTM) | 2.94% | N/A |
| ROIC 5YR AVG | 8.25% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 75.72% | 13.43% | -1.94% |
| Revenue | -1.62% | 31.67% | 17.95% |
| Net Income | 78.07% | 12.70% | -2.28% |
| Cash Flow | 29.37% | -65.92% | 44.37% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.79 | N/A |
| Quick Ratio (TTM) | 0.93 | N/A |
| D/E Ratio (TTM) | 0.66 | N/A |
| Interest Coverage (TTM) | 1.95 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.49 | N/A |
| LTL to 5YR AVG FCF | 24.27 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.13% | N/A |